Who invested in Mablink Bioscience?
Mablink Bioscience's investors include Sofinnova Partners and Elaia.
France · Series A startup
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2022, from 1 source
Mablink Bioscience's investors include Sofinnova Partners and Elaia.
Mablink Bioscience has raised $30M across 1 round since 2022.
Mablink Bioscience's most recent round was a Series A of $30M in Oct 2022.
Its most recent round, $30M in Oct 2022, is also its largest on record.
Mablink Bioscience's first round on record, in Oct 2022, was backed by Sofinnova Partners and Elaia.
Mablink Bioscience's latest named round is a Series A, in Oct 2022.
Mablink Bioscience is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.